Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Fast Five Quiz: Plaque Psoriasis ... Biologic Failure in Psoriasis A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

China’s National Medical Products Administration has given the thumbs up to Akeso Pharmaceuticals Inc.’s ebdarokimab for treating moderate to severe plaque psoriasis in adults. An interleukin ...

The favorable data provided support for two ongoing phase III, randomized, placebo-controlled trials of ESK-001 in moderate/severe plaque psoriasis ... Treatment New targets and drugs are just ...

Icotrokinra appears to be an effective treatment for adolescents with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

On lighter skin, plaque ... medications such as biologics, which are derived from natural sources and target the immune system. Although psoriasis causes and treatment do not differ by skin ...

"The addition of STEQEYMA to the Costco Member Prescription Program together ... infusion and is indicated for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA) in adult ...

“Adolescents living with moderate to severe plaque psoriasis shouldn’t have to wait for effective treatment options that have the potential to deliver completely clear skin, which is the ...